How M.D. was paid
$2.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Barbara Weber, M.D.Executive Chairman | $697,950 | $308,096 | $1,275,328 | $524,250 | $18,368 | $2,823,992 |
| Daniella BeckmanFormer Chief Financial Officer | $502,877 | $76,006 | $314,617 | $244,117 | $18,158 | $1,155,775 |
| Adam Crystal, M.D., Ph.D.President of Research and Development | $588,638 | $154,274 | $638,597 | $321,468 | $18,103 | $1,721,080 |
What changed and why
- $2.8MBarbara Weber earned total compensation of $2,823,992 in 2025, down from $6,541,200 in 2024.
- $698KHer base salary for 2025 was $697,950 compared to $659,996 previously.
- $308KStock awards totaled $308,096 and option awards were $1,275,328.
- $524KNon-equity incentive plan compensation for Dr. Weber was $524,250.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.